NDC 0409-0806-11 - Cefazolin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0409-0806
Requested NDC
0409-0806-11
Package NDCs from labels
0409-0806-11, 0409-0806-01
Manufacturer
Hospira, Inc.
Effective date
2018-08-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefazolin for Injection, USPHospira, Inc.2018-08-30HUMAN PRESCRIPTION DRUG LABEL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-0806-01EA - Each0409-080661e2f050-8b1b-4863-9b24-c86f5a0f7b6212012-07-24
0409-0806-11EA - Each0409-08065e74d8e7-da86-4473-aa19-ba0b5a8460e812016-07-19

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Cefazolin SodiumACTIVE INGREDIENTP380M0454ZCEFAZOLIN INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]8
CefazolinACTIVE MOIETYIHS69L0Y4TCEFAZOLIN INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]8

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 33 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.06091653-e568-4e82-acc7-aefbce16de172024-04-18Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINQilu Pharmaceutical Co., Ltd.e8bd9e95-8af5-416b-b58c-e1dbe3d052ac2023-12-18Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.37a626aa-96dc-4c4d-bfbc-be4f328f918b2023-12-15Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.0e8d4462-7642-4296-a605-6c1493e91ffd2023-12-14Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.81d1783a-2baa-4d65-856a-f5ce38d248042023-12-14Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CEFAZOLINCEFAZOLIN SODIUMFresenius Kabi USA, LLCc47c8d14-1eef-40f9-9d11-f0c300b1d4be2023-09-27Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINA-S Medication Solutions8a772acc-726d-40e6-88ee-b6075cbf9b282023-06-23Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINMedical Purchasing Solutions, LLC6673be13-4c74-70b9-e053-2a91aa0a211d2023-06-01Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINMedical Purchasing Solutions, LLC79787707-c84f-f229-e053-2a91aa0a1f162023-05-16Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINProficient Rx LPd24529e3-e2b4-46d6-81ba-b7da745017922022-08-01Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINSandoz Ince58f87fb-a47d-4081-a454-e4e916e2f6292020-09-08Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLIN SODIUMFresenius Kabi USA, LLC47a8928f-708d-418a-829b-36eded96bac02020-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
8d0d5e66-6887-4140-9136-d767096550dafae6b455-db4f-4250-a700-794f8a6999602019-11-26Warnings, Adverse reactionsExact identifier
spl set id: fae6b455-db4f-4250-a700-794f8a699960

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.